Skip to main content

Table 1 LV functional analysis

From: Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis

 ControlDay 14Day 21
LVEF (%)66 (6)65 (8)47 (16) †
LVM (mg)345 (33)348 (72)545 (156) *
LVM/BW (mg/g)1.46 (0.27)2.22 (0.54) †3.01 (0.99) †
LVEDV (μl)361 (34)245 (37) †309 (22) †
LVEDV/BW (μl/g)1.52 (0.24)1.56 (0.22)1.69 (0.15)
LVESV (μl)121 (16)86 (17) †163 (55)
LVESV/BW (μl/g)0.50 (0.02)0.54 (0.13)0.90 (0.33) †
BW (g)239 (25)158 (14) †183 (15) †
  1. LV function was analyzed on cine CMR. Mean (SD) of LVEF, LVM, LVM/BW, LVEDV, LVEDV/BW, LVESV, LVESV/BW, and BW of the control, early phase (day 14), and peak phase (day 21) groups are shown. [BW = body weight. Statistical analysis; * p = 0.01, †p < 0.01 compared to the control.] LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVM, left ventricular mass